Infection Control Conference - 11.5 CME Points

Theme

Addressing hospital and community infection prevention & control

 

Overview

The Infection Control Conference welcomes world renowned, internationally educated speakers and policy makers, with distinct experience within the GCC region.

This two day programme has been carefully developed to strategically address infections acquired both within the hospital and within the community.

Day 1 presents a highly anticipated scientific meeting tailored to all infection control professionals, physicians and allied health workers. The engaging expert-led sessions will discuss antimicrobial resistance within the region, whilst also providing evidence based practical solutions to the growing problem.

Unique insights on antimicrobial stewardship, epidemiology, multi-drug resistance surveillance and management strategy will be addressed through a national and global kaleidoscope. Additionally, the programme will explore the specific surgical approaches to tackle AMR whilst also addressing dialysis technique.

Delegates will be able to take away the latest techniques to improve antibiotic practice, resulting in effective management of antimicrobial resistance.

Day 2 provides delegates with an evidence based programme that will discuss the most effective strategies related to diagnosis, prevention and management of common infectious diseases as well as updated and novel concepts related to infection control.

With a focus on the community and HCAI’s, delegates will advance their knowledge concerning the management of upper respiratory infections whilst also gaining a unique insight into the pathogenesis of more common infections.

Benefits of attending:

  • Review the most recent surveillance data and evaluate epidemiological factors to appraise factors influencing antimicrobial resistance
  • Discover advanced infection control methods and alternatives to antibiotics in infection management to help reduce antimicrobial resistance
  • Review how the neonatal intensive care unit (NICU), peadiatric intensive care unit (PICU) and generalintensive care unit (ICU) departments can collaboratively work together to improve infection control
  • Discuss the role of antimicrobial stewardship programmes for better clinical practice in regional healthcare establishments
  • Review best practice for the management of upper respiratory infections enabling better patient outcomes

Key topics:

  • Sepsis
  • Updates in epidemiology and surveillance
  • Antimicrobial stewardship (AMS)
  • Advanced approaches to overcome AMR
  • Effective management of upper respiratory infections
  • Healthcare associated infections: new challenges and new solutions
  • Big data, bioinformatics and infectious diseases
  • The role of the gut microbiome in infection control

Who should attend?

  • Infectious Disease Consultants/Physicians                      
  • Family Practice Physicians
  • Infection Preventionists                                                          
  • Internal Medicine and Subspecialties Physicians
  • Infection Control Managers                                                   
  • Laboratory Technologists
  • Infection Control Coordinators  
  • Patient Safety Officers
  • Epidemiologists                
  • Pathologists                      
  • Microbiologists
  • Medical Laboratory Supervisors
  • Medical Technologists                  
  • Public Health Professionals                         
  • Nurses 
  • General Practitioners    
  • Intensivists                        

 

Scientific Committee

Activity Director:

Dr Adnan Alatoom, Clinical Pathologist, Pathology & Laboratory Medicine Institute, Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE 

Co-Activity Director: 

Dr Hussian Al Awadhi, Consultant Intensivist, Pulmonologist and Chief of Medical Intensive Care, Mafraq
Hospital, Abu Dhabi, UAE

Local Chair:

Dr Mansour Al Zarouni, Member, General Secretariat Committee, Sultan Bin Khalifa International Thalassemia Award (SITA), Dubai, UAE

 

CME CONFERENCES - FACULTY DISCLOSURE STATEMENT:


The Cleveland Clinic Foundation Center for Continuing Education has implemented a policy to comply with the current Accreditation Council for Continuing Medical Education Standards for Commercial Support requiring resolution for all faculty conflicts of interest. Faculty declaring a relevant interest will be identified in the activity syllabus.

DAY 1: Saturday, 27 October 2018
09:00 Opening remarks by Conference Chair:
Dr Mansour Al Zarouni, Member, General Secretariat Committee, Sultan Bin Khalifa International Thalassemia Award (SITA), Dubai, UAE
SESSION 1
09:10

Critical thinking in Sepsis: Role of Biomarkers

Prof Manaf Al-Qahtani, Consultant Internist & Infectious Diseases - Medical Department; Senior Microbiology Lecturer, The Royal College of Surgeons in Ireland – Medical University of Bahrain, Clinical Microbiologist, Head of Microbiology, Pathology and Laboratory Medicine, Royal Medical Services, Bahrain Defense Force Hospital, Ar-Rifaa, Bahrain

09:40

Septic shock, what we are not doing good

Dr Hussian Al Awadhi, Consultant Intensivist, Pulmonologist and Chief of Medical Intensive Care, Mafraq Hospital, Abu Dhabi, UAE

10:10 Interactive Q & A
10:30

Coffee Break

SESSION 2
11:00

Pan drug-resistant, what shall I do other than praying?
Dr Murat Akova, Professor of Medicine, Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey

11:30

Establishing infection control programmes within new hospitals 
Dr Shafi Mohammed, Acting Director, Infection Prevention & Control, Cleveland
Clinic, Abu Dhabi, UAE

12:00

Interactive Q & A

12:20

Lunch Break

SESSION 3
13:20 How microbiologists can help right the antimicrobial stewardship ship
13:50

New BLBLI antibiotics, where & how can I use them?    

Dr Murat Akova, Professor of Medicine, Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey

14:20

Interactive Q & A

14:30

Coffee Break

SESSION 4
15:00

Title tbc

Dr Najiba M Abdulrazzaq, Consultant Internist, Head of Medical
Department, Al Baraha Hospital, Head of Infection Prevention and Control
Central Committee, Ministry of Health & Prevention, Dubai, UAE

15:30

Molecular testing impact on HAI’s

Prof Manaf Al-Qahtani, Consultant Internist & Infectious Diseases - Medical Department; Senior Microbiology Lecturer, The Royal College of Surgeons in Ireland – Medical University of Bahrain, Clinical Microbiologist, Head of Microbiology, Pathology and Laboratory Medicine, Royal Medical Services, Bahrain Defence Force Hospital, Ar-Rifaa, Bahrain

16:00 Interactive Q & A
DAY 2: Sunday, 28 October 2018
08:50 Opening remarks by Conference Chair:
Dr Mansour Al Zarouni, Member, General Secretariat Committee, Sultan Bin Khalifa International Thalassemia Award (SITA), Dubai, UAE
SESSION 5
09:00

Bundle sin ICU for infection control     

Dr Hussain Al Awadhi, Consultant Intensivist, Pulmonologist and Chief of Medical Intensive Care, Mafraq Hospital, Abu Dhabi, UAE

09:30

The basics of NGS: an overview of sequencing and what we
can learn from it

Dr Paul G Higgins, Lab Head, Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany

10:00 Interactive Q & A
10:30

Coffee Break

SESSION 6
11:00

Application of NGS in the microbiology laboratory for outbreak analysis

Dr Paul G Higgins, Lab Head, Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Cologne, Germany

11:30

Role of Quantiferon Gold Plus in identifying active tuberculosis amongst healthcare workers

Prof Ashok Rattan, Adviser: Lab Operations, PathKind Labs, New Delhi Area, India

12:20 Lunch Break
13:20

Colistin resistance in Enterobacteriaceae – farms, labs, clinics and hospitals

Dr Tibor Pál, Professor of Microbiology, Consultant Clinical Microbiologist, Dept. Medical Microbiology and Immunology, UAE University, Al Ain, UAE

SESSION 7
13:50

Hypervirulent Klebsiella pneumoniae - an emerging threat

Dr Ágnes Sonnevend, Associate Professor, Consultant Clinical Microbiologist, Dept. of Medical Microbiology and Immunology, College of Medicine and Health Sciences, UAE University, Al Ain, UAE

14:20 Interactive Q & A
14:30

Cofee Break

SESSION 8
15:00

Monitoring the changes in the Gut Microbiome: Diabetes

Dr P. K Menon, Director, Laboratory Services, Director, The Center for Advanced Biomedical Research and Innovation (CABRI), Gulf Medical University (GMU), Thumbay Group, Ajman, UAE

15:30

Opportunistic infections in the immunocompromised host and infection control challenges

Dr Hafiz Ahmed, Assistant Professor of Microbiology, RAK College of Medical Sciences, Clinical Microbiologist, RAK Hospital, Ras Al Khaimah, UAE

16:00 Interactive Q & A
16:20 Closing remarks
16:50 End of Infection Control conference

Dr Adnan Alatoom

Staff Physician, Clinical Pathology and Microbiology, Pathology & Laboratory Medicine Institute

Cleveland Clinic Abu Dhabi, Abu Dhabi, UAE


Dr Mansour Al Zarouni

Member, General Secretariat Committee

Sultan Bin Khalifa International Thalassemia Award (SITA), Dubai, UAE


Dr Hussain Abdulaziz Alawadhi

Division Chief Physician - Critical Care Medicine - Physician Practice Services

Al Mafraq Hospital, Abu Dhabi, UAE


Dr Agnes Sonnevend

Associate Professor, Consultant Clinical Microbiologist, Medical Microbiology and Immunology, CMHS

UAE University, Al Ain, UAE




Dr Hafiz Ahmed

Assistant Professor of Microbiology

RAK College of Medical Sciences, Clinical Microbiologist, RAK Hospital, Ras Al Khaimah, UAE



Dr Manaf Al-Qahtani

Consultant Internist & Infectious Diseases - Medical Department; Senior Microbiology Lecturer

The Royal College of Surgeons in Ireland – Medical University of Bahrain, Clinical Microbiologist, Head of Microbiology, Pathology and Laboratory Medicine, Royal Medical Services, Bahrain Defense Force Hospital, Ar-Rifaa, Bahrain



Dr Murat Akova

Professor of Medicine, Infectious Diseases

Hacettepe University School of Medicine, Ankara, Turkey

Dr Najiba M Abdulrazzaq,

Consultant Internist, Head of Medical Department

Al Baraha Hospital

Head of Infection Prevention and Control Central Committee

Ministry of Health
& Prevention, Dubai, UAE


Dr Paul G Higgins

Lab Head, Institute for Medical Microbiology

Immunology and Hygiene University of Cologne, Cologne, Germany


Dr P.K Menon

Director, Laboratory Services, Director

The Center for Advanced Biomedical Research and Innovation (CABRI), Gulf Medical University (GMU), Thumbay Group, Ajman, UAE


Dr Shafi Mohammed

Acting Director,
Infection Prevention & Control

Cleveland
Clinic, Abu Dhabi, UAE

Dr Tibor Pal

Professor of Microbiology; Consultant Clinical Microbiologist, Dept. Medical Microbiology and Immunology, FMHS

UAE University, Al Ain, UAE



Provided by

Accreditation Statement:

The Cleveland Clinic Foundation Center for Continuing Education is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

The Cleveland Clinic Foundation Center for Continuing Education designates this live activity for the maximum of 11.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants claiming CME credit from this activity may submit the credit hours to the American Osteopathic Association for Category 2 credit.